Tirzepatide, a groundbreaking medication, represents a significant advance in the approach of type 2 diabetes mellitus and, more recently, excess body fat. This dual activator acts upon two crucial chemicals: incretin hormone and GIP. Unlike traditional diabetes drugs, Tirzepatide promotes not only production of insulin when blood sugar are elevate